• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2022年中国上海奥密克戎BA.2毒株疫情期间无症状和有症状患者的病毒载量动态变化:一项纵向队列研究

Viral load dynamics in asymptomatic and symptomatic patients during Omicron BA.2 outbreak in Shanghai, China, 2022: A longitudinal cohort study.

作者信息

Ai Jingwen, Zhou Jiaxin, Li Yang, Sun Feng, Ge Shijia, Zhang Haocheng, Wu Yanpeng, Wang Yan, Zhang Yilin, Wang Hongyu, Cai Jianpeng, Zhou Xian, Wang Sen, Li Rong, Feng Zhen, Xu Xiangyanyu, Yan Xuemei, Zhao Yuchen, Zhang Juanjuan, Yu Hongjie, Zhang Wenhong

机构信息

Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200433, China.

School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai 200433, China.

出版信息

Virol Sin. 2024 Dec;39(6):851-859. doi: 10.1016/j.virs.2024.10.001. Epub 2024 Oct 11.

DOI:10.1016/j.virs.2024.10.001
PMID:39396663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11738783/
Abstract

The SARS-CoV-2 virus, particularly the Omicron BA.2 variant, led to a significant surge in Shanghai, 2022. However, the viral load dynamic in Omicron infections with varying clinical severities remain unclear. This prospective cohort included 48,830 hospitalized coronavirus disease 2019 (COVID-19) patients across three hospitals in Shanghai, China, between 23 March and 15 May, 2022. Systematic nucleic acid testing was performed using RT-PCR Cycle threshold (Ct) value as a proxy of viral load. We analyzed the kinetic characteristics of viral shedding by clinical severity and identified associated risk factors. The study comprised 31.06% asymptomatic cases, 67.66% mild-moderate cases, 1.00% severe cases, 0.29% critical and fatal cases. Upon admission, 57% of patients tested positive, with peak viral load observed at 4 days (median Ct value 27.5), followed by a decrease and an average viral shedding time (VST) of 6.1 days (Interquartile range, 4.0-8.8 days). Although viral load exhibited variation by age and clinical severity, peak Ct values occurred at similar times. Unvaccinated status, age exceeding 60, and comorbidities including hypertension, renal issues kidney dialysis and kidney transplantation, neurological disorders, rheumatism, and psychotic conditions were found to correlate with elevated peak viral load and extended VST. Asymptomatic cases demonstrated a 40% likelihood of contagiousness within 6 days of detection, while mild-moderate and severe cases exhibited post-symptom resolution infectious probabilities of 27% and over 50%, respectively. These findings revealed that the initial Ct values serve as a predictive indicator of severe outcomes. Unvaccinated elderly individuals with particular comorbidities are at high-risk for elevated viral load and prolonged VST.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒,尤其是奥密克戎BA.2变体,在2022年导致上海疫情大幅激增。然而,不同临床严重程度的奥密克戎感染中的病毒载量动态仍不清楚。这项前瞻性队列研究纳入了2022年3月23日至5月15日期间中国上海三家医院的48830例住院的2019冠状病毒病(COVID-19)患者。使用逆转录聚合酶链反应(RT-PCR)循环阈值(Ct)值作为病毒载量的指标进行系统核酸检测。我们分析了不同临床严重程度下病毒脱落的动力学特征,并确定了相关风险因素。该研究包括31.06%的无症状病例、67.66%的轻中度病例、1.00%的重度病例、0.29%的危重症和死亡病例。入院时,57%的患者检测呈阳性,病毒载量在4天达到峰值(中位数Ct值为27.5),随后下降,平均病毒脱落时间(VST)为6.1天(四分位间距,4.0 - 8.8天)。尽管病毒载量因年龄和临床严重程度而有所不同,但峰值Ct值出现在相似的时间。未接种疫苗状态、年龄超过60岁以及包括高血压、肾脏问题(肾透析和肾移植)、神经系统疾病、风湿病和精神疾病在内的合并症与峰值病毒载量升高和VST延长相关。无症状病例在检测后6天内具有40%的传染可能性,而轻中度和重度病例在症状缓解后的感染概率分别为27%和超过50%。这些发现表明,初始Ct值可作为严重结局的预测指标。患有特定合并症的未接种疫苗的老年人病毒载量升高和VST延长的风险很高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/2ae2347092f6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/21e6fee221bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/ab3b49b3e23a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/8bef54da1f73/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/52dd47a5b549/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/2ae2347092f6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/21e6fee221bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/ab3b49b3e23a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/8bef54da1f73/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/52dd47a5b549/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f52/11738783/2ae2347092f6/gr5.jpg

相似文献

1
Viral load dynamics in asymptomatic and symptomatic patients during Omicron BA.2 outbreak in Shanghai, China, 2022: A longitudinal cohort study.2022年中国上海奥密克戎BA.2毒株疫情期间无症状和有症状患者的病毒载量动态变化:一项纵向队列研究
Virol Sin. 2024 Dec;39(6):851-859. doi: 10.1016/j.virs.2024.10.001. Epub 2024 Oct 11.
2
Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study.中国上海奥密克戎毒株流行期间无症状和轻症感染者疾病特征及病毒RNA衰减动态:一项回顾性队列研究
Int J Infect Dis. 2023 May;130:60-70. doi: 10.1016/j.ijid.2023.02.020. Epub 2023 Feb 25.
3
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.SARS-CoV-2 G614 感染(武汉株)患者新冠病毒载量随症状出现和严重程度的变化轨迹。
JAMA Netw Open. 2022 Jan 4;5(1):e2142796. doi: 10.1001/jamanetworkopen.2021.42796.
4
Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant infection in Shanghai: A multicenter, retrospective, observational study.与上海 SARS-CoV-2 奥密克戎变异株感染病毒持续排出相关的因素:一项多中心、回顾性、观察性研究。
J Med Virol. 2023 Dec;95(12):e29342. doi: 10.1002/jmv.29342.
5
Kinetics of Viral Shedding for Outbreak Surveillance of Emerging Infectious Diseases: Modeling Approach to SARS-CoV-2 Alpha and Omicron Infection.用于新发传染病暴发监测的病毒脱落动力学:SARS-CoV-2 Alpha 和 Omicron 感染的建模方法。
JMIR Public Health Surveill. 2024 Sep 19;10:e54861. doi: 10.2196/54861.
6
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.新冠病毒感染后症状患者中,新冠病毒(SARS-CoV-2)的病毒动力学:对香港感染原始株和奥密克戎 BA.2 患者的回顾性观察研究。
Lancet Microbe. 2023 Sep;4(9):e722-e731. doi: 10.1016/S2666-5247(23)00146-5.
7
Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.韩国社区治疗中心中无症状和有症状的 SARS-CoV-2 感染患者的临床病程和分子病毒脱落情况。
JAMA Intern Med. 2020 Nov 1;180(11):1447-1452. doi: 10.1001/jamainternmed.2020.3862.
8
Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai.上海地区 SARS-CoV-2 奥密克戎变异株感染轻症和无症状患者病毒脱落时间的临床特征及影响因素分析。
Front Public Health. 2023 Jan 4;10:1073387. doi: 10.3389/fpubh.2022.1073387. eCollection 2022.
9
Vaccination status for mild and asymptomatic infections with SARS-CoV-2 Omicron BA.2 variant in Shanghai.上海市 SARS-CoV-2 奥密克戎 BA.2 变异株轻症和无症状感染者的疫苗接种情况。
J Med Virol. 2023 May;95(5):e28767. doi: 10.1002/jmv.28767.
10
Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study.上海一项多中心、回顾性、观察性研究显示,合并症使感染 SARS-CoV-2 奥密克戎变异株的患者病毒脱落时间延长。
J Infect Public Health. 2023 Feb;16(2):182-189. doi: 10.1016/j.jiph.2022.12.003. Epub 2022 Dec 6.

引用本文的文献

1
The potential mechanisms and material basis of Fuzheng Jiedu decoction broad-spectrum inhibiting coronaviruses.扶正解毒汤广谱抑制冠状病毒的潜在机制及物质基础
Virol Sin. 2025 Feb;40(1):125-136. doi: 10.1016/j.virs.2024.12.007. Epub 2024 Dec 28.

本文引用的文献

1
Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant infection in Shanghai: A multicenter, retrospective, observational study.与上海 SARS-CoV-2 奥密克戎变异株感染病毒持续排出相关的因素:一项多中心、回顾性、观察性研究。
J Med Virol. 2023 Dec;95(12):e29342. doi: 10.1002/jmv.29342.
2
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.新冠病毒感染后症状患者中,新冠病毒(SARS-CoV-2)的病毒动力学:对香港感染原始株和奥密克戎 BA.2 患者的回顾性观察研究。
Lancet Microbe. 2023 Sep;4(9):e722-e731. doi: 10.1016/S2666-5247(23)00146-5.
3
Vaccine effectiveness in symptom and viral load mitigation in COVID-19 breakthrough infections in South Korea.
疫苗对韩国 COVID-19 突破性感染症状和病毒载量减轻的效果。
PLoS One. 2023 Aug 16;18(8):e0290154. doi: 10.1371/journal.pone.0290154. eCollection 2023.
4
Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias.在一项考虑了感染后时间相关采样偏差的、针对 SARS-CoV-2 的具有代表性的人群研究中,病毒载量与年龄、疫苗接种和病毒变异有关。
PLoS Pathog. 2023 Aug 14;19(8):e1011461. doi: 10.1371/journal.ppat.1011461. eCollection 2023 Aug.
5
Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China.急性感染 SARS-CoV-2 奥密克戎变异株(B.1.1.529)的病毒和抗体动态:来自中国深圳的前瞻性队列研究。
Lancet Microbe. 2023 Aug;4(8):e632-e641. doi: 10.1016/S2666-5247(23)00139-8. Epub 2023 Jul 14.
6
Association Between Cycle Threshold Value and Vaccination Status Among Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Cases in Ontario, Canada, in December 2021.2021年12月加拿大安大略省严重急性呼吸综合征冠状病毒2奥密克戎变种病例中循环阈值与疫苗接种状况之间的关联
Open Forum Infect Dis. 2023 May 22;10(6):ofad282. doi: 10.1093/ofid/ofad282. eCollection 2023 Jun.
7
Persistence of SARS-CoV-2 RNA shedding and infectivity in immunized population: Prospective study along different epidemiological periods in Argentina.免疫人群中 SARS-CoV-2 RNA 脱落和传染性的持续存在:阿根廷不同流行期的前瞻性研究。
PLoS One. 2023 May 17;18(5):e0285704. doi: 10.1371/journal.pone.0285704. eCollection 2023.
8
Viral dynamics of SARS-CoV-2 in immunocompromised patients.免疫功能低下患者体内 SARS-CoV-2 的病毒动力学。
Clin Microbiol Infect. 2023 Aug;29(8):1087.e1-1087.e3. doi: 10.1016/j.cmi.2023.05.013. Epub 2023 May 13.
9
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study.帕罗韦德治疗成人重症新型冠状病毒肺炎的疗效和安全性:一项多中心随机对照研究
Lancet Reg Health West Pac. 2023 Apr;33:100694. doi: 10.1016/j.lanwpc.2023.100694. Epub 2023 Feb 6.
10
Low SARS-CoV-2 Cq values in healthcare workers with symptomatic COVID-19 infections, regardless of symptom severity, The Netherlands, January to August 2022.2022 年 1 月至 8 月荷兰,有症状 COVID-19 感染的医护人员中无论症状严重程度如何,SARS-CoV-2 的 Ct 值都较低。
Euro Surveill. 2023 Jan;28(4). doi: 10.2807/1560-7917.ES.2023.28.4.2300007.